Umutlu L - Search Results

1

Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.

Karpinski MJ, Hüsing J, Claassen K, Möller L, Kajüter H, Oesterling F, Grünwald V, Umutlu L, Kleesiek J, Telli T, Merkel-Jens A, Hüsing A, Kesch C, Herrmann K, Eiber M, Hoberück S, Meyer PT, Kind F, Rahbar K, Schäfers M, Stang A, Hadaschik BA, Fendler WP. Karpinski MJ, et al. Among authors: umutlu l. Lancet Oncol. 2024 Sep;25(9):1188-1201. doi: 10.1016/S1470-2045(24)00326-7. Epub 2024 Jul 29. Lancet Oncol. 2024. PMID: 39089299 Free article.

2

¹⁸F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?

Kirchner J, Deuschl C, Grueneisen J, Herrmann K, Forsting M, Heusch P, Antoch G, Umutlu L. Kirchner J, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1005-1013. doi: 10.1007/s00259-017-3635-2. Epub 2017 Feb 4. Eur J Nucl Med Mol Imaging. 2017. PMID: 28161723

3

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.

Kirchner J, Sawicki LM, Suntharalingam S, Grueneisen J, Ruhlmann V, Aktas B, Deuschl C, Herrmann K, Antoch G, Forsting M, Umutlu L. Kirchner J, et al. Among authors: umutlu l. PLoS One. 2017 Feb 22;12(2):e0172553. doi: 10.1371/journal.pone.0172553. eCollection 2017. PLoS One. 2017. PMID: 28225831 Free PMC article.

4

Imaging children suffering from lymphoma: an evaluation of different ¹⁸F-FDG PET/MRI protocols compared to whole-body DW-MRI.

Kirchner J, Deuschl C, Schweiger B, Herrmann K, Forsting M, Buchbender C, Antoch G, Umutlu L. Kirchner J, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1742-1750. doi: 10.1007/s00259-017-3726-0. Epub 2017 May 22. Eur J Nucl Med Mol Imaging. 2017. PMID: 28534182

5

Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.

Erfanian Y, Grueneisen J, Kirchner J, Wetter A, Podleska LE, Bauer S, Poeppel T, Forsting M, Herrmann K, Umutlu L. Erfanian Y, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1823-1831. doi: 10.1007/s00259-017-3736-y. Epub 2017 May 31. Eur J Nucl Med Mol Imaging. 2017. PMID: 28567495

6

18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.

Kirchner J, Sawicki LM, Deuschl C, Grüneisen J, Beiderwellen K, Lauenstein TC, Herrmann K, Forsting M, Heusch P, Umutlu L. Kirchner J, et al. Among authors: umutlu l. PLoS One. 2017 Jul 6;12(7):e0180349. doi: 10.1371/journal.pone.0180349. eCollection 2017. PLoS One. 2017. PMID: 28683109 Free PMC article.

7

Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix.

Sarabhai T, Schaarschmidt BM, Wetter A, Kirchner J, Aktas B, Forsting M, Ruhlmann V, Herrmann K, Umutlu L, Grueneisen J. Sarabhai T, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):67-76. doi: 10.1007/s00259-017-3809-y. Epub 2017 Aug 24. Eur J Nucl Med Mol Imaging. 2018. PMID: 28840302

8

Comparison of ¹⁸F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study.

Sawicki LM, Kirchner J, Grueneisen J, Ruhlmann V, Aktas B, Schaarschmidt BM, Forsting M, Herrmann K, Antoch G, Umutlu L. Sawicki LM, et al. Among authors: umutlu l. Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):622-629. doi: 10.1007/s00259-017-3881-3. Epub 2017 Nov 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29164299

9

Diagnostic accuracy of ¹⁸F-FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma.

Ruhlmann V, Poeppel TD, Veit J, Nagarajah J, Umutlu L, Hoffmann TK, Bockisch A, Herrmann K, Sauerwein W. Ruhlmann V, et al. Among authors: umutlu l. BMC Cancer. 2017 Dec 22;17(1):887. doi: 10.1186/s12885-017-3890-4. BMC Cancer. 2017. PMID: 29273015 Free PMC article.

10

Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging.

Al-Bayati M, Grueneisen J, Lütje S, Sawicki LM, Suntharalingam S, Tschirdewahn S, Forsting M, Rübben H, Herrmann K, Umutlu L, Wetter A. Al-Bayati M, et al. Among authors: umutlu l. Urol Int. 2018;100(2):164-171. doi: 10.1159/000484695. Epub 2018 Jan 25. Urol Int. 2018. PMID: 29393268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters